Tristel plc

387.50pAs of Sun 8 Nov 2026, 12:00 UTC
LSE:TSTLHealthcare
Ctry United Kingdom
PE (Fwd) •••
TSR 10Y CAGR 12.07%
Div yield 3.85%
ROE 23.24%
Medical Instruments & Supplies
Beta (5Y) 0.33
PE TTM 23.39
TSR TTM 8.86%
Mkt cap £186.3M
ROIC 31.81%
SE Grade™
Value
Quality
Moat
Consensus
Reference
429p
10.64%
(86.25%)
Hold 5|1|1|1|4
2Q26
3Q26
4Q26
1Q27
Earnings per share£
3.54
3.94
3.95
3.95
8.65%
22.58%
26.29%
19.49%
Revenue£M
10.01
10.40
10.96
11.37
1.61%
1.07%
7.21%
11.11%
Peers (US$250.7M)
Cap (US$)
PE
825.5M
171.0x
362.4M
39.25x
127.8M
—
Capital
TTM
5Y
10Y
Leveragex
0.140
0.206
0.213
EBIT/Intx
0.859
0.034
0.032
Own earn%
112.27
10.47
27.66
Sh yield%
30.13
48.03
44.95
Owners
Insiders/Inst%
6.91
29.16
Short interest%
2.97
SBC / revenue%
5.38
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
11–15
$1 testx
—
Incr. ROIC%
4